SBS says Embecta investors may seek lead plaintiff role in securities class action
The law firm says the case concerns investors who bought Embecta shares between Nov. 25, 2025, and May 4, 2026.
Schall, Brown & Schwartz LLP said Aug. 3 it is seeking lead plaintiff candidates in a securities class action against Embecta Corp., alleging the company made false and misleading statements about fiscal guidance for the second quarter and full-year 2026.
The firm said the case involves investors who bought Embecta shares between Nov. 25, 2025, and May 4, 2026. It said the lawsuit alleges violations of Section 10(b) and Section 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5.
SBS said lead plaintiff status can affect how a securities class action proceeds. The firm also said the class has not yet been certified.
According to the press release, the complaint says Embecta gave investors the impression it had a reliable basis for its guidance for the second quarter and full-year 2026 while knowing that headwinds in some markets, including the pen needle market, were likely to affect performance against that guidance.
SBS said the complaint alleges Embecta’s public statements were false and materially misleading during the class period. The firm also said investors suffered damages after the market learned the truth about the company.
The press release describes Schall, Brown & Schwartz as a national shareholder rights litigation firm. It names Brian Schall and David Schwartz as contacts and lists the firm’s Los Angeles office, phone number, website and email.
The firm said shareholders who bought EMBC shares during the class period are encouraged to contact it about possible lead plaintiff appointments. It said investors who take no action may remain absent class members.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
Comments ()